Table 1.
Drug | Effect | Possible application |
---|---|---|
ROCK inhibitor | Corneal endothelial cell regeneration | Topical eye drops for recovery of corneal clarity in corneal endothelial dysfunction |
Promotion of corneal endothelial cell adhesion | Adjuvant therapy for the corneal endothelial cell injection | |
| ||
Blood-derived products | Promotion of healing of ocular surface epithelium | Recovery of persistent epithelial defect or neurotrophic keratitis |
Promoting ocular surface regeneration and prevention of corneal haze after ocular chemical injury or keratorefractive surgery | ||
| ||
Growth factors | Facilitation of corneal epithelial healing and nerve regeneration | Treatment of persistent epithelial defect or neurotrophic keratitis |
Topical eye drops for diabetic keratopathy | ||
Recovery of cornea epithelium and nerve after keratorefractive surgery | ||
| ||
RGTA∗ | Promotion of corneal regeneration and attenuation of ocular surface inflammation | Treatment of persistent epithelial defect or neurotrophic keratitis |
Recovery of corneal epithelium after corneal cross-linking | ||
Corneal recovery after keratorefractive surgery |
∗RGTA: regenerating agent eye drops.